Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Merck Earnings: What Investors Need to Know

The big pharma stocks are all reporting their first-quarter results, and Merck's (NYSE: MRK  ) beginning of 2014 was decidedly mixed. The company missed Wall Street expectations on the top line as revenue declined 4% thanks in part to generic competition, but adjusted earnings came in better than expected at $0.88 per share. Merck has a lot of rumors swirling around it right now, as it may be about to sell off two divisions and raise as much as $30 billion, but before any of these changes happen, investors should get a better grasp of Merck as it currently stands.

In this segment from Market Checkup, The Motley Fool's health care-focused investing show, analysts David Williamson and Michael Douglass dig into Merck and its earnings report this quarter. Find out what really mattered in the big pharma's quarter, why shares soared 3%, and why Merck's R&D cutting will come back to haunt it. 

6 stock picks poised for incredible growth
They said it couldn't be done. But David Gardner has proved them wrong time, and time, and time again with stock returns like 926%, 2,239%, and 4,371%. In fact, just recently one of his favorite stocks became a 100-bagger. And he's ready to do it again. You can uncover his scientific approach to crushing the market and his carefully chosen six picks for ultimate growth instantly, because he's making this premium report free for you today. Click here now for access.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2942236, ~/Articles/ArticleHandler.aspx, 9/3/2015 3:34:04 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

David Williamson

The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...

Today's Market

updated Moments ago Sponsored by:
DOW 16,389.83 38.45 0.24%
S&P 500 1,953.56 4.70 0.24%
NASD 4,748.75 -1.23 -0.03%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/3/2015 3:17 PM
MRK $52.97 Down -0.01 -0.02%
Merck & Co., Inc. CAPS Rating: ****